The Neurology Podcast provides practical information for neurologists and clinicians to practice the
Dr. Justin Abbatemarco talks with Drs. John Chen and Smathorn Thakolwiboon about the outcomes follow
The July 2025 recall features four episodes on systems and innovation in delivering neurologic care.
Dr. Dan Ackerman talks with Drs. Luuk Dekker and Jasper D. Daems about analyzing various anterior-ci
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about several studies presented at the 2025 E
Dr. Elizabeth Coon talks with Dr. Peter Novak about how central sensitization plays a role in the au
Dr. Jeff Ratliff talks with Dr. Brin E. Freund about the evaluated incidence and risk factors for ac
Dr. Halley Alexander talks with Dr. Serena Yin about the effectiveness of an electronic medical reco
Dr. Halley Alexander talks with Dr. Samuel W. Terman about patients' perceived seizure risk, seizure
Dr. Katie Krulisky talks with Dr. Leah Blank about the impact of outpatient follow-up on readmission
Dr. Halley Alexander talks with Dr. Coral M. Stredny about the management of pediatric convulsive st
Dr. Nadia Khalil talks with Dr. Jean Bouchart about the diagnostic approach to intracerebral hemorrh
The June 2025 replay features four previously released stroke episodes. It begins with Dr. Cheryl Bu
Dr. Justin Abbatemarco talks with Drs. Sumanth Reddy and Jeffrey Gelfand about the complexities of s
Dr. Greg Cooper talks with Dr. David A. Wolk about limbic predominant age-related TDP-43 encephalopa
Dr. Stacey Clardy talks with Dr. Elia Sechi about the importance of understanding lab test results,
Dr. Roy E. Strowd talks with Dr. Susannah Cornes about a teaching incentive initiative designed to s
Dr. Jeff Ratliff talks with Dr. Per Borghammer about the classification of Lewy body disease into br
Dr. Stacey Clardy talks with Dr. Janis Miyasaki about her journey into neurology, the integration of
Dr. Jessica Ailani talks with Dr. Kathleen Digre about the evolution of spontaneous intracranial hyp
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alz